Telix Pharmaceuticals | TLX - Ebit

Stock Price
13.89
Daily Change
0.31 2.25%
Monthly
36.13%
Yearly
-43.14%
Q2 Forecast
12.67

Telix Pharmaceuticals reported AUD8.04M in EBIT for its fiscal semester ending in December of 2025.





Ebit Change Date
Cochlear AUD 261.1M 13.9M Dec/2025
CSL USD 2.64B 116M Dec/2025
Integral Diagnostics AUD 24.99M 5.08M Jun/2024
Mayne Pharma AUD -16.2M 13.2M Jun/2024
Medical Developments International AUD -36K 12.96M Dec/2025
Mesoblast USD -27.75M 14.36M Dec/2025
Neuren Pharmaceuticals AUD 17.01M 154.09M Dec/2025
Pacific Edge NZD -19.4M 2.91M Dec/2025
Paradigm Biopharmaceuticals AUD -21.57M 11.26M Dec/2025
Polynovo AUD 2.06M 1.18M Dec/2025
PYC Therapeutics AUD -22.59M 3.25M Dec/2025
Ramsay Health Care AUD 541.1M 20.7M Dec/2025
ResMed USD 497.6M 35.25M Dec/2025
Sonic Healthcare AUD 423.94M 80.3M Dec/2024